Eupraxia Pharmaceuticals Inc. (EPRX)

Eupraxia Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	19.77	33.1	19.34	18.26	16.51	0.12
Short-Term Investments	-	-	-	-	7.12	-
Cash & Short-Term Investments	19.77	33.1	19.34	18.26	23.63	0.12
Cash Growth	-15.23%	71.14%	5.91%	-22.70%	19954.27%	-86.78%
Other Receivables	0.13	0.23	0.19	0.09	0.34	0.49
Receivables	0.13	0.23	0.19	0.09	0.34	0.49
Prepaid Expenses	2.93	1.11	0.27	0.24	0.21	0.29
Total Current Assets	22.83	34.44	19.8	18.59	24.18	0.89
Property, Plant & Equipment	0.69	0.42	0.46	0.53	0.47	0.25
Other Long-Term Assets	0.08	0.08	0.01	0	0.02	-
Total Assets	23.6	34.94	20.27	19.12	24.67	1.14
Accrued Expenses	2.55	3.01	3.87	2.91	1.67	2.38
Short-Term Debt	-	-	-	-	-	9.82
Current Portion of Long-Term Debt	-	-	10.4	0.08	0.08	-
Current Portion of Leases	0.04	0.07	0.05	0.05	0.05	0.04
Current Income Taxes Payable	-	-	0.04	-	-	-
Other Current Liabilities	0.03	0.02	5.02	0.02	0	5.44
Total Current Liabilities	2.62	3.1	19.37	3.06	1.79	17.69
Long-Term Debt	-	-	-	8.8	7.66	-
Long-Term Leases	-	-	-	0.05	0.11	0.16
Other Long-Term Liabilities	-	-	-	-	-	0.3
Total Liabilities	2.62	3.1	19.37	11.91	9.56	18.14
Common Stock	117.12	116.36	92.91	71	61.36	18.68
Additional Paid-In Capital	23.03	20.5	17.51	16.85	-	4.86
Retained Earnings	-146.51	-131	-105.5	-77.28	-58.68	-40.18
Comprehensive Income & Other	-2.79	-4.16	-2.71	-2.79	13.09	-
Total Common Equity	-9.15	1.7	2.22	7.79	15.77	-16.65
Minority Interest	-1.58	-1.57	-1.32	-0.58	-0.66	-0.36
Shareholders' Equity	20.98	31.84	0.89	7.21	15.11	-17
Total Liabilities & Equity	23.6	34.94	20.27	19.12	24.67	1.14
Total Debt	0.04	0.07	10.45	8.99	7.9	10.02
Net Cash (Debt)	19.73	33.03	8.89	9.28	15.73	-9.9
Net Cash Growth	5.76%	271.55%	-4.18%	-41.03%	-	-
Net Cash Per Share	0.55	0.97	0.37	0.48	1.27	-1.62
Filing Date Shares Outstanding	35.96	35.85	35.62	27.36	14.24	12.87
Total Common Shares Outstanding	35.62	35.64	27.28	21.59	14.24	6.18
Working Capital	20.21	31.33	0.43	15.53	22.39	-16.8
Book Value Per Share	-0.26	0.05	0.08	0.36	1.11	-2.69
Tangible Book Value	-9.15	1.7	2.22	7.79	15.77	-16.65
Tangible Book Value Per Share	-0.26	0.05	0.08	0.36	1.11	-2.69
Buildings	-	-	-	-	0.07	0.07
Machinery	1.08	0.7	0.68	0.61	0.1	0.07
Leasehold Improvements	0.12	0.12	0.13	0.13	0.13	0.08

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q